INTERNATIONAL PATENT: NANJING ANJI BIOTECHNOLOGY CO., LTD., 南京安吉生物科技有限公司 FILES APPLICATION FOR "MICROPEPTIDE MP19 REGULATING CHOLESTEROL METABOLISM AND USE THEREOF"

GENEVA, Feb. 2 -- NANJING ANJI BIOTECHNOLOGY CO., LTD. (6F, Block A7, Hongfeng Technology Park, Nanjing Economic-technological Development AreaNanjing, Jiangsu 210033), 南京安吉生物科技有限公司 (中国江苏省南京市经济技术开发区红枫科技园A7栋6层) filed a patent application (PCT/CN2025/110588) for "MICROPEPTIDE MP19 REGULATING CHOLESTEROL METABOLISM, AND USE THEREOF" on Jul 25, 2025. With publication no. WO/2026/021572, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted un...